Existing measures of breast size dissatisfaction have poor ecological validity or have not been fully evaluated in terms of psychometric properties. Here, we report on the development of the Breast Size Rating Scale (BSRS), a novel measure of breast size dissatisfaction consisting of 14 computer-generated images varying in breast size alone. Study 1 (N=107) supported the scale's construct validity, insofar as participants were able to correctly order the images in terms of breast size. Study 2 (N=234) provided evidence of the test-retest reliability of BSRS-derived scores after 3 months. Studies 3 (N=730) and 4 (N=234) provided evidence of the convergent validity of BSRS-derived breast size dissatisfaction scores, which were significantly associated with a range of measures of body image. The BSRS provides a useful tool for researchers examining women's breast size dissatisfaction.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bodyim.2015.02.004 | DOI Listing |
Healthcare (Basel)
December 2024
Department of Sport Sciences, University of Beira Interior, Convento de Santo António, 6201-001 Covilhã, Portugal.
Background: Breast cancer treatments often cause serious side effects, but physical exercise has shown the potential to improve both the physical and psychological health outcomes of survivors. This review and meta-analysis aimed to synthesize and analyze the scientific evidence on the effectiveness of concurrent training on physical, psychological, and biomarkers variables on breast cancer survivors.; Methods: A systematic review and meta-analysis was registered in PROSPERO (CRD42024571851).
View Article and Find Full Text PDFAngew Chem Int Ed Engl
January 2025
The University of Sydney, School of Chemistry, Buiding F11, Easyern Avenue, 2006, Sydney, AUSTRALIA.
Amphiphilic bottlebrush block copolymers (BBCs) with tadpole-like, coil-rod architecture can be used to self-assemble into functional polymer nanodiscs directly in water. The hydrophobic segments of the BBC were tuned via the ratio of ethoxy-ethyl glycidyl ether (EE) to tetrahydropyranyl glycidyl ether (TP) within the grafted polymer sidechains. In turn, this variation controlled the sizes, pH-responsiveness, and drug loading capacity of the self-assembled nanodiscs.
View Article and Find Full Text PDFCureus
December 2024
Pathology, BLDE (Deemed to be University) Shri B M Patil Medical College, Hospital and Research Centre, Vijayapura, IND.
Background Breast carcinoma cases are rising steadily and represent a major cause of mortality and morbidity in India. In response to breast carcinoma, the immune system is activated, resulting in lymphocyte infiltration in and around the tumor nests. This interaction between the tumor and immune system is the basis for studying tumor-infiltrating lymphocytes (TILs).
View Article and Find Full Text PDFPurpose: In prostate and breast cancer, moderate hypofractionation (HF) has demonstrated comparable, if not greater, efficacy than conventional fractionation. There is a stark disparity in the uptake of HF between North America and Africa. Using the Consolidative Framework for Implementation Research, we evaluated barriers and facilitators for implementing HF in Sub-Saharan Africa (SSA).
View Article and Find Full Text PDFBiotechnol Appl Biochem
January 2025
Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamil Nadu, India.
Globally, breast cancer continues to be the leading type of cancer affecting women, with rising mortality rates projected by 2030. This highlights the importance of developing new, affordable treatments, like drug delivery systems that use nanoparticles. Gold nanoparticles (AuNPs), including their exceptional optical and physical attributes, make them an attractive vehicle for targeted treatment, allowing for accurate and focused delivery of medication directly to cancerous cells while reducing harmful side effect.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!